Dana Mowls Carroll, PhD, MPH

Tobacco Research Programs Director

 

Dr. Dana Carroll

Dana Mowls Carroll, PhD, MPH is an Associate Professor in the Division of Environmental Health Sciences at the University of Minnesota, a member of the Masonic Cancer Center, University of Minnesota, a University of Minnesota McKnight Presidential Fellow, and the Director of the Tobacco Research Programs. 

Dr. Carroll is an epidemiologist and certified tobacco treatment specialist with a research program that focuses on describing commercial tobacco use patterns and determinants (via large-scale epidemiologic studies like NIDA/FDA’s Population Assessment of Tobacco Use and Health) and addressing commercial tobacco use (via clinical trials of smoking cessation interventions and potential cigarette product standards). Many of her research studies incorporate community-engaged research principles (e.g. convening local and national constituent advisory councils to help inform and guide the research). In 2023 and 2024, Dr. Carroll was awarded the Early Career Investigator Award from the National Institute on Minority Health and Health Disparities (NIMHD), National Institutes of Health (NIH) and the Jarvik-Russell Award (an early career investigator award) from the Society for Research on Nicotine and Tobacco.

Dr. Carroll has received several NIH-funded grants (i.e., R36, K01, R21, R13, R01). To date, most of her research entails collaborating with American Indian and rural populations to combat cigarette smoking. In 2023, her contributions to helping American Indian people quit smoking were highlighted as part of President Biden’s White House Cancer Moonshot Agenda to end cancer as we know it.  In addition, Dr. Carroll has served as a co-investigator on multiple NIH-funded clinical trials evaluating potential cigarette product standards. These trials seek to inform the actions of the FDA Center for Tobacco Products who regulate tobacco products for the protection of public health.


Founder & Former Director

Dr. Dorothy Hatsukami

Dorothy Hatsukami, PhD

Dr. Hatsukami is known for her research in the areas of nicotine addiction and treatment of nicotine addiction among a general population of adult smokers as well as adolescents. She has also conducted research in the area of smokeless tobacco. Her most recent research has primarily been focused on developing methods and measures to evaluate tobacco products and she has led an effort to develop a trandisciplinary team (both institutionally and nationally) around this topic. She has also concentrated her efforts on exploring and developing the science base for policies that might reduce tobacco-caused death and disease such as reducing the toxicity and nicotine in tobacco products. 

Because of her expertise, Dr. Hatsukami has served on a number of national committees including the National Advisory Council for Substance Abuse and Mental Health Services Administration, National Advisory Council on Drug Abuse, the Interagency Committee for Smoking and Health, Drug Control Research, Data, and Evaluation Committee for the Office of National Drug Control Policy, the Institute of Medicine and on the Scientific Board of Counselors for the Intramural Research Program of NIDA. She has also served on the Tobacco Product Scientific Advisory Committee for the Food and Drug Administration. She has served on many advisory panels for other federal, non- profit and international organizations. She is a past president of the Society on Research on Nicotine and Tobacco and a past president of the College on Problems of Drug Dependence.

Location

Tobacco Research Programs
717 Delaware St SE
Minneapolis, MN 55414

Fax: 612-624-4610
Email: [email protected]

Masonic Cancer Center, University of Minnesota in maroon text to the right of a maroon block M